Table 6. Primary outcome (Clomipramine studies); cessation and reduction of at least 90%.

Study name	Intervention	Total N	Event rate	Odds ratio with 95% CI and significance of global estimate
Dehasse [1]	Clomipramine	26	0.35	2.12 [0.54–8.26]
Landsberg & Wilson [33]	Clomipramine	25	0.68	8.50 [2.14–33.81]
King et al. [19]	Clomipramine	18	0.61	6.29 [1.48–26.76]
Hart et al. [21]	Clomipramine	6	0.33	2.00 [0.27–15.08]
Global estimate				4.23 [2.00–8.93] P<0.0001

Heterogeneity: P>0.10.